Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0P3BS
|
|||
| Former ID |
DNCL003027
|
|||
| Drug Name |
TUTI-16
|
|||
| Indication | Human immunodeficiency virus-1 infection [ICD-11: 1C62; ICD-10: B20-B24] | Phase 1/2 | [1] | |
| Company |
Thymon
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01335191) Clinical Study of TUTI-16 in Asymptomatic HIV-1 Infected Subjects (THYMON-11001). U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.